Punit Dhillon
Insider
First SEC filing: Jan. 23, 2018 · Latest: Jan. 23, 2018
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | SKYE | A | 1,090,000 | · | · | 1,419,823 Direct | +330.48% | Acquired | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | A | 250,000 | · | · | 250,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | D | 250,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | A | 36,000 | · | · | 36,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | D | 36,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | A | 12,360 | · | · | 12,360 Direct | · | Acquired | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | D | 12,360 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | A | 650,000 | · | · | 650,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | D | 650,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | A | 125,000 | · | · | 125,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | D | 125,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | A | 9,013 | · | · | 9,013 Direct | · | Acquired | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | D | 9,013 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | A | 21,586 | · | · | 21,586 Direct | · | Acquired | (price as of 2026-10-02) |
| March 31, 2026 | SKYE | D | 21,586 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Feb. 6, 2026 | SKYE | A | 280,000 | · | · | 280,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 24, 2025 | SKYE | A | 250,000 | · | · | 250,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 18, 2024 | SKYE | S | 82,546 | $4.99 | $411,905 | 329,823 Direct | -20.02% | Disposed | -95.8% (price as of 2026-10-02) |
| Nov. 15, 2024 | SKYE | S | 364 | $5.55 | $2,020 | 412,369 Direct | -0.09% | Disposed | -96.2% (price as of 2026-10-02) |
| Oct. 28, 2024 | SKYE | A | 650,000 | · | · | 650,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 26, 2024 | SKYE | J | 15,727 | · | · | 412,733 Direct | +3.96% | Acquired | (price as of 2026-10-02) |
| Feb. 29, 2024 | SKYE | A | 100,000 | · | · | 397,006 Direct | +33.67% | Acquired | (price as of 2026-10-02) |
| Feb. 29, 2024 | SKYE | A | 125,000 | · | · | 125,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 29, 2024 | SKYE | A | 100,000 | · | · | 397,006 Direct | +33.67% | Acquired | (price as of 2026-10-02) |
| Feb. 29, 2024 | SKYE | A | 125,000 | · | · | 125,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 6, 2023 | SKYE | A | 194,270 | · | · | 297,006 Direct | +189.10% | Acquired | (price as of 2026-10-02) |
| Nov. 6, 2023 | SKYE | A | 21,586 | · | · | 30,599 Direct | +239.50% | Acquired | (price as of 2026-10-02) |
| Aug. 29, 2023 | SKYE | P | 881,000 | $0.02 | $17,620 | 25,683,957 Direct | +3.55% | Acquired | -95.8% (price as of 2026-10-02) |
| Aug. 29, 2023 | SKYE | P | 881,000 | $0.02 | $17,620 | 41,554,828 Direct | +2.17% | Acquired | -95.8% (price as of 2026-10-02) |
| Aug. 28, 2023 | SKYE | L | 110,000 | $0.02 | $2,200 | 24,802,957 Direct | +0.45% | Acquired | -95.8% (price as of 2026-10-02) |
| Aug. 28, 2023 | SKYE | L | 110,000 | $0.02 | $2,200 | 40,673,828 Direct | +0.27% | Acquired | -95.8% (price as of 2026-10-02) |
| Aug. 25, 2023 | SKYE | A | 20,277,414 | · | · | 24,683,957 Direct | +460.17% | Acquired | (price as of 2026-10-02) |
| Aug. 25, 2023 | SKYE | A | 2,253,046 | · | · | 2,253,046 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 25, 2023 | SKYE | A | 20,277,414 | · | · | 40,554,828 Direct | +100.00% | Acquired | (price as of 2026-10-02) |
| Aug. 25, 2023 | SKYE | A | 2,253,046 | · | · | 2,253,046 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 23, 2023 | SKYE | L | 9,000 | $0.01 | $90 | 24,692,957 Direct | +0.04% | Acquired | -91.6% (price as of 2026-10-02) |
| Aug. 23, 2023 | SKYE | L | 9,000 | $0.01 | $90 | 40,563,828 Direct | +0.02% | Acquired | -91.6% (price as of 2026-10-02) |
| Nov. 10, 2022 | SKYE | A | 1,406,543 | · | · | 4,406,543 Direct | +46.88% | Acquired | (price as of 2026-10-02) |
| Nov. 10, 2022 | SKYE | A | 2,335,721 | · | · | 2,335,721 Indirect | · | Acquired | (price as of 2026-10-02) |
| Nov. 10, 2022 | SKYE | A | 390,000 | · | · | 390,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 10, 2022 | SKYE | A | 390,000 | · | · | 390,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 10, 2022 | SKYE | A | 487,500 | · | · | 487,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 10, 2022 | SKYE | A | 292,500 | · | · | 292,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 14, 2021 | SKYE | A | 2,000,000 | · | · | 3,000,000 Direct | +200.00% | Acquired | (price as of 2026-10-02) |
| Dec. 14, 2021 | SKYE | A | 3,090,000 | · | · | 3,090,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 7, 2020 | SKYE | P | 1,000,000 | $100000.00 | $100,000,000,000 | 1,000,000 Direct | · | Acquired | -100.0% (price as of 2026-10-02) |
| Aug. 7, 2020 | SKYE | A | 9,000,000 | · | · | 9,200,000 Direct | +4500.00% | Acquired | (price as of 2026-10-02) |
| Oct. 10, 2018 | SKYE | A | 200,000 | · | · | 200,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 30, 2009 | INO | A | 75,000 | $1.57 | $117,750 | 75,000 Direct | · | Acquired | -98.5% (price as of 2026-10-02) |
| Dec. 9, 2008 | INO | A | 70,000 | $0.50 | $35,000 | 70,000 Direct | · | Acquired | -95.2% (price as of 2026-10-02) |
| July 9, 2008 | INO | A | 60,000 | $1.06 | $63,600 | 60,000 Direct | · | Acquired | -97.7% (price as of 2026-10-02) |
| Feb. 1, 2008 | INO | A | 50,000 | $0.87 | $43,500 | 50,000 Direct | · | Acquired | -97.2% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | · | Feb. 25, 2035 | 250,000 | Acquired |
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | $2.89 | Feb. 25, 2035 | 250,000 | Disposed |
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | · | Aug. 7, 2030 | 36,000 | Acquired |
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | $11.25 | Aug. 7, 2030 | 36,000 | Disposed |
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | · | Dec. 14, 2031 | 12,360 | Acquired |
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | $14.50 | Dec. 14, 2031 | 12,360 | Disposed |
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | · | Oct. 27, 2034 | 650,000 | Acquired |
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | $5.15 | Oct. 27, 2034 | 650,000 | Disposed |
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | · | March 1, 2034 | 125,000 | Acquired |
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | $14.56 | March 1, 2034 | 125,000 | Disposed |
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | · | Nov. 6, 2033 | 9,013 | Acquired |
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | $3.50 | Nov. 6, 2033 | 9,013 | Disposed |
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | · | Sept. 29, 2033 | 21,586 | Acquired |
| March 31, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | $3.50 | Sept. 29, 2033 | 21,586 | Disposed |
| Feb. 6, 2026 | SKYE | Stock Option (Right to Buy) | Common Stock | $0.82 | Feb. 6, 2036 | 280,000 | Acquired |
| Feb. 24, 2025 | SKYE | Stock Option (Right to Buy) | Common Stock | $2.89 | Feb. 25, 2035 | 250,000 | Acquired |
| Oct. 28, 2024 | SKYE | Stock Option (Right to Buy) | Common Stock | $5.15 | Oct. 27, 2034 | 650,000 | Acquired |
| Feb. 29, 2024 | SKYE | Stock Option (Right to Buy) | Common Stock | $14.56 | March 1, 2034 | 125,000 | Acquired |
| Feb. 29, 2024 | SKYE | Stock Option (Right to Buy) | Common Stock | $14.56 | March 1, 2034 | 125,000 | Acquired |
| Nov. 6, 2023 | SKYE | Stock Option (Right to Buy) | Common Stock | $3.50 | Aug. 25, 2033 | 21,586 | Acquired |
| Aug. 25, 2023 | SKYE | Stock Option (Right to Buy) | Common Stock | $0.01 | Aug. 25, 2033 | 2,253,046 | Acquired |
| Aug. 25, 2023 | SKYE | Stock Option (Right to Buy) | Common Stock | $0.01 | Aug. 25, 2033 | 2,253,046 | Acquired |
| Nov. 10, 2022 | SKYE | Stock Option (Right to Buy) | Common Stock | $1.60 | April 3, 2024 | 390,000 | Acquired |
| Nov. 10, 2022 | SKYE | Stock Option (Right to Buy) | Common Stock | $0.11 | Feb. 6, 2025 | 390,000 | Acquired |
| Nov. 10, 2022 | SKYE | Stock Option (Right to Buy) | Common Stock | $0.06 | April 27, 2025 | 487,500 | Acquired |
| Nov. 10, 2022 | SKYE | Stock Option (Right to Buy) | Common Stock | $0.08 | Aug. 3, 2025 | 292,500 | Acquired |
| Dec. 14, 2021 | SKYE | Stock Option (Right to Buy) | Common Stock | $0.06 | Dec. 14, 2031 | 3,090,000 | Acquired |
| Aug. 7, 2020 | SKYE | Employee Option Grant (Right to Buy) | Common Stock | $0.04 | Aug. 7, 2030 | 9,000,000 | Acquired |
| Oct. 10, 2018 | SKYE | Director Stock Option (Right to Buy) | Common Stock | $0.30 | Oct. 10, 2028 | 200,000 | Acquired |
| Sept. 30, 2009 | INO | Common Stock Option | Common Stock | $1.57 | Sept. 30, 2019 | 75,000 | Acquired |
| Dec. 9, 2008 | INO | Common Stock Option | Common Stock | $0.50 | Dec. 9, 2018 | 70,000 | Acquired |
| July 9, 2008 | INO | Common Stock Option | Common Stock | $1.06 | July 9, 2018 | 60,000 | Acquired |
| Feb. 1, 2008 | INO | Common Stock Option | Common Stock | $0.87 | Feb. 1, 2018 | 50,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 9 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 23, 2018 | SKYE | No securities beneficially owned. | 0 | Direct |
| Jan. 30, 2008 | INO | Inovio Biomedical Corporation Common Stock | 185 | Direct |
| Jan. 30, 2008 | INO | Inovio Biomedical Corporation Common Stock Option | 25,000 | Direct |
| Jan. 30, 2008 | INO | Inovio Biomedical Corporation Common Stock Option | 6,250 | Direct |
| Jan. 30, 2008 | INO | Inovio Biomedical Corporation Common Stock Option | 15,000 | Direct |
| Jan. 30, 2008 | INO | Inovio Biomedical Corporation Common Stock Option | 35,000 | Direct |
| Jan. 30, 2008 | INO | Inovio Biomedical Corporation Common Stock Option | 40,000 | Direct |
| Jan. 30, 2008 | INO | Inovio Biomedical Corporation Common Stock Option | 15,000 | Direct |
| Jan. 30, 2008 | INO | Inovio Biomedical Corporation Common Stock Warrants | 1,029 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2008 | $171,876 | · | · | $85,517 | · | · | $3,900 | $261,293 |
| 2007 | $145,736 | $13,300 | · | $94,025 | · | · | $3,900 | $256,961 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $610,000 | · | · | · | $219,600 | · | · | $1,361,831 |
| 2024 | $458,333 | · | · | · | $255,763 | · | · | $6,139,625 |
| 2023 | $450,000 | · | · | · | $270,000 | · | · | $1,807,338 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.